Skip to content Skip to footer

Incyte News

HomeAll PostsIncyte News

7 Biotech Stocks That Could Cure Your Portfolio Woes

FDA Approves Incyte Drug for Rare Skin Cancer Merkel Cell Carcinoma

Incyte MacroGenics win FDA nod for rare skin cancer therapy (NASDAQ:INCY)

Caris signs research partnership with Incyte for oncology pipeline

Caris Life Sciences and Incyte Enter Into Broad Precision Medicine Partnership to Advance Incyte’s Oncology Pipeline

Building A Healthier Future With Software, Surgery And Solar Energy

Caris Life Sciences, Incyte Partner To Advance Incyte’s Oncology Pipeline

Incyte reports new data from hidradenitis suppurativa therapy trial

M&A Frenzy: Incyte & Villaris, AmplifyBio & PACT, Estrella Earns Nasdaq Listing (Updated)